Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Research Instruments Corporation is a private Rhode Island company developing compact liquid metal target-based X-ray source technologies and X-ray imaging devices for scientific, medical, and industrial use. Its core product platform, LPXSource, is a laser-driven plasma X-ray source designed to outperform conventional X-ray tubes with higher brightness, compact form factor, ultrafast pulsed operation, and low maintenance requirements. The company positions its technology for OEM integration into next-generation analytical instruments and medical imaging systems. Research Instruments has also highlighted phase-contrast and advanced X-ray imaging processing capabilities intended to improve image resolution while reducing radiation dose, including potential applications in mammography and lung imaging. In addition to healthcare applications, it is pursuing industrial inspection uses such as lithium-ion battery quality control and non-destructive testing.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Research Instruments Corporation.